The link between cmv and atherosclerosis

Infections in Medicine

Volumn 15, Issue 7, 1998, Pages 479-486

  Melnick, Joseph L ^a   Adam, Ervin ^b   Debakey, Michael E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Division of Molecular Virology   (United States)

Author keywords

Atherosclerosis; Cytomegalovirus (CMV); Herpes simplex virus (hsv); Polymerase chain reaction (pcr)

Indexed keywords

EID: 0000863591     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pétrie BL, Adam E, Melnick JL: Association of herpesvirus/cytomegalovirus infections with human atherosclerosis. Prog Med Virol 35:21-38,1988.
2. Speir E, Modali R, Huang E-S, et al: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 165:391-394,1994.
3. Benditt EP, Barrett T, McDougall JK: Viruses in the etiology of atherosclerosis. Proc Natl Acad Sei U S A 80:6386-6389,1983.
4. Ross R: The pathogenesis of atherosclerosis: An update. N Engl J Med 314:488-500,1986.
5. Fabricant CG, Fabricant J, Litrenta MM, et al: Virus-induced atherosclerosis. J Exp Med 148:335-340,1978.
6. Fabricant CG, Fabricant J, Minick CR, et al: Herpesvirus-induced atherosclerosis in chickens. Fed Pfoc 42:2476-2479,1983.
7. Shih JCH, Pullman RP, Jao KJ: Genetic selection, general characterization, and history of atherosclerosis-susceptible and -resistant Japanese quail. Atherosclerosis 49:41-53,1983.
8. Hajjar DP, Fabricant CG, Minick CR, et al: Virus-induced atherosclerosis: Hcrpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 122:6270,1986.
9. Melnick JL, Adam E, DeBakey ME: Cytomegalovirus and atherosclerosis. Eur Heart J 14(suppl K):30-38,1993.
10. Benditt EP, Benditt JM: Evidence for monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sei USA 70:17531756,1973.
11. Penn A, Garte SJ, Warren L, et al: Transforming gene in atherosclerotic plaque DMA. Proc Natl Acad Sei U S A 83:79517955,1986.
12. Behbehani AM, Melnick JL, DeBakey ME: Continuous cell strains derived from human atheromatous lesions and their viral susceptibility. Proc Soc Exp Biol Med 228:759763,1965.
13. Melnick JL, Adam E, DeBakey ME: Cytomegalovirus and atherosclerosis. Bioessays 17:899-903,1995.
14. Yamashiroya HM, Ghoch L, Yang R, et al: Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 130:71-79,1988.
15. Bruggeman CA, van Dam-Mieras MC: The possible role of cytomegalovirus in atherogenesis. Prog Med Virol 38:1-26,1991.
16. Hendrix MGR, Dormans PHJ, Kitslaar P, et al: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol 134:23-28,1989.
17. Melnick JL, Hu C, Burek J, et al: Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 42:170174,1994.
18. Tanaka S, Toh Y, Mori R, et al: Possible role of cytomegalovirus in the pathogenesis of inflammatory aortic disease. J Vase Surg 16:274-279,1992.
19. \Vu TC, Hruban RH, Ambinder RF, et al: Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 140:739-747,1992.
20. Min KW, Wickemeyer WJ, Chandran P, et al: Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: A case report. J Heart Transplant 6:100-105,1987.
21. Sorlie PD, Adam E, Melnick SL, et al: Cytomegalovirus/herpesvirus and carotid atherosclerosis: The ARIC Study. J Med Virol 42:33-37,1994.
22. Zhou YF, Léon MB, Waclawiw MA, et al: Association between prior cytomegalovirus infection and the risk of restenosis after cor-onary atherectomy. N Engl J Med 335:624630,1996.
23. Lemstrom KB, Bruning JM, Bruggeman CA, et al: Cytomcgalovirus infection enhances smooth muscle cell proliferation and intimai thickening of rat aortic allografts. J Clin Invest 92:549-538,1993.
24. Nieto FJ, Adam E, Sorlie P, et al: Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94(5}:922-927,1996.
25. Adam E, Melnick JL, Probtsfield JL, et al: High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2:291-293,1987.
26. Grattan MT, Moreno-Cabral CE, Starnes VA, et al: Cytomcgalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566,1989.
27. Span AJM, van Boven CFA, Bruggeman CA: The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest 19:542-548,1989.
28. Visser MR, Jacob HS, Goodman JL, et al: Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab Invest 60:296-304,1989.
29. Key S, Vercellotti GM, Winkelmann JD, et al: Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sei USA 87:7095-7099,1990.
30. Smiley ML, Mar E-C, Huang E-S: Cytomegalovirus infection and viral-induced transformation of human epithelial cells. J Med Virol 25:213-226,1988.
31. Smirnov VN, Bystrevskaya V, Pampou SY, et al: Cytomegalovirus Infection of Human Aortic Endothelium. International Symposium on Atherosclerosis, Paris, 1997.
32. Vossen RC, van Dam-Mieras MC, Bruggeman CA: Cytomegalovirus infection and vessel wall pathology. Intervirology 39(3):213-226,1996.
33. Etingin OR, Silverstein RL, Hajjar DP: Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc Natl Acad Sei U S A 88:7200- 7203,1991.
34. Dummer S, Lee A, Breinig MK, et al: Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 44:305309,1994.